NRGene Overview
NRGene is a genomics company that provides turn-key software solutions for agricultural breeding companies. Using algorithms and extensive proprietary databases, the company enables breeders to achieve higher quality and more productive yields. The company has assembled over 500 genomes for dozens of species including wheat, corn, soy, tomato, cannabis, cattle, and rainbow trout. NRGene's tools have been implemented by agricultural biotechnology companies and academic research teams worldwide. NRGene collaborates with more than 100 customers, ranging from small companies to large corporations like Syngenta, Bayer, BASF, and Toyota, as well as many academic institutions.
Cumulative Funding Raised Over Time ($)
$7.2MDec 2016
$8.2MFeb 2010
$11.7MJan 2015
Latest News
growth-positive
NRGene Announced First Successful Commercialization of ToBRFV-Resistant Tomatoes
NRGene has announced the commercial sales of its High Resistance (HR) tomato seeds, developed in partnership with Philoseeds, which offer enhanced protection against the Tomato Brown Rugose Fruit Virus (ToBRFV). Following successful pilot plots in Switzerland and Canada, these seeds are now being adopted at a commercial scale. The HR trait, validated through rigorous testing, is licensed to over a dozen companies across Europe, South Africa, and the USA. HW Seeds is among the first to integrate this trait into its commercial varieties, with customers like PurNatur reporting strong performance and high fruit quality. This development marks a significant milestone in combating ToBRFV and supporting global tomato production.
Product StageCustomersPartners
growth-positive
/PRNewswire/ -- NRGene (TASE: NRGN) announced the commercial sales of tomato seeds carrying its High Resistance (HR) trait to Tomato Brown Rugose Fruit Virus...
NRGene has announced the commercial sales of its tomato seeds with a High Resistance (HR) trait to the Tomato Brown Rugose Fruit Virus (ToBRFV), developed in partnership with Philoseeds. These seeds have been successfully tested in Switzerland and Canada, demonstrating strong resistance and premium fruit quality. The HR trait has been licensed to multiple companies across Europe, South Africa, and the USA. HW Seeds is one of the first to integrate this trait into its commercial varieties, with positive feedback from growers like PurNatur. This development marks a significant milestone for NRGene, showcasing its ability to rapidly bring innovative solutions to market and address critical challenges in the agriculture industry.
Product StageCustomersPartners
growth-positive
/CNW/ -- NRGene Green, a global leader in AI-driven genomics for crop improvement, today announced breakthrough field trial results confirming complete...
NRGene Green, a leader in AI-driven genomics for crop improvement, announced a breakthrough in field trials demonstrating complete resistance to clubroot in canola. This innovation, developed in Saskatchewan, marks the first field demonstration of immunity-level resistance to this disease, offering significant value to Canadian agriculture. The trials showed that NRGenes advanced donor lines achieved 0% disease incidence, outperforming existing industry standards. This breakthrough is expected to transform global oilseed production, providing Canadian farmers with robust defense against clubroot. The resistant lines are now available for licensing to commercial breeding programs, opening opportunities for seed companies to secure these traits. NRGene Greens technology combines genomics and AI tools to identify natural resistance genes, supporting rapid regulatory acceptance and global deployment.
Product StagePartners
growth-positive
NRGene Achieves Full Clubroot Resistance in Canola and Moves Toward Commercialization in Canada
NRGene Green, a leader in AI-driven genomics for crop improvement, has announced groundbreaking field trial results demonstrating complete resistance to clubroot in canola. This innovation, developed in Saskatchewan, is a significant advancement for Canadian agriculture, offering robust defense against a disease that threatens global oilseed production. The trials showed that NRGenes advanced donor lines achieved 0% disease incidence, outperforming existing industry standards. This breakthrough is expected to enhance food security and drive sustainable agricultural practices worldwide.
Product Stage
growth-positive
Middle Eastern Market: 3 Penny Stocks With Market Caps Over US$10M To Watch
Apex Investment PSC, a company with a market capitalization of AED13.40 billion, has reported significant earnings growth despite a decline in sales. For Q2 2025, the companys net income increased to AED97.2 million from AED18.74 million the previous year, with a substantial rise in basic earnings per share. Apex Investment PSC operates in the manufacturing, distribution, and sale of clinkers and cement products, primarily deriving revenue from its Catering segment. Despite having no debt and strong short-term asset coverage, the company experienced decreased profit margins due to one-off losses. The board is considered experienced, with an average tenure of 3.3 years.
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | $42.3M |
| Last funding | $30.6M |
| Stage | Public |
| Rounds | 4 |
| Investors | 0 |
Team Members
6
Employees: 11-50
Web & Social Links
| Website | nrgene.com |
| Careers | Careers page |
Locations
Golda Meir Street 5, Ness Ziona, Israel
8910 University Center Lane, San Diego, CA, USA
Photos & Videos
2 item(s)
NRGene Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Climate TechFood & Land UseSustainable FarmingAgriculture & Food TechnologiesAg TechGenetics & InputTarget Customer
Agriculture & FoodCropsCore Technology
Artificial IntelligenceBiologicalsGenesTags (18)
agtechbiotechnologyplant-genomicssoftware-applicationscropslivestockbreedingbioinformaticsclimate-techbig-data-analyticsgenomicsagriculturegeneticssmart-farmingfood-and-beverageartificial-intelligenceacademiacannabisGeographic Markets
CanadaEuropeUnited StatesJapanSouth AmericaEast AsiaGlobalNRGene Financials
$42.3M
Total funding
Undisclosed
Capital raised
$30.6M
Last funding
Public
Funding stage
4
Total rounds
0
Investors
Cumulative Funding Raised Over Time ($)
$7.2MDec 2016
$8.2MFeb 2010
$11.7MJan 2015
Private Equity Funding
B Round
Dec 2016
$7.2M
A Round
Jan 2015
$3.5M
Seed
Feb 2010
$1M
Public Offering / Exit
POEvent
Jan 2021
Undisclosed
NRGene Lifecycle
Cumulative Funding Raised Over Time
$7.2MDec 2016
$8.2MFeb 2010
$11.7MJan 2015
All Events
B Round
Dec 2016
$7.2M
A Round
Jan 2015
$3.5M
Seed
Feb 2010
$1M
POEvent
Jan 2021
Undisclosed
NRGene News
56 articles
growth-positive
NRGene Announced First Successful Commercialization of ToBRFV-Resistant Tomatoes
NRGene has announced the commercial sales of its High Resistance (HR) tomato seeds, developed in partnership with Philoseeds, which offer enhanced protection against the Tomato Brown Rugose Fruit Virus (ToBRFV). Following successful pilot plots in Switzerland and Canada, these seeds are now being adopted at a commercial scale. The HR trait, validated through rigorous testing, is licensed to over a dozen companies across Europe, South Africa, and the USA. HW Seeds is among the first to integrate this trait into its commercial varieties, with customers like PurNatur reporting strong performance and high fruit quality. This development marks a significant milestone in combating ToBRFV and supporting global tomato production.
Product StageCustomersPartners
growth-positive
/PRNewswire/ -- NRGene (TASE: NRGN) announced the commercial sales of tomato seeds carrying its High Resistance (HR) trait to Tomato Brown Rugose Fruit Virus...
NRGene has announced the commercial sales of its tomato seeds with a High Resistance (HR) trait to the Tomato Brown Rugose Fruit Virus (ToBRFV), developed in partnership with Philoseeds. These seeds have been successfully tested in Switzerland and Canada, demonstrating strong resistance and premium fruit quality. The HR trait has been licensed to multiple companies across Europe, South Africa, and the USA. HW Seeds is one of the first to integrate this trait into its commercial varieties, with positive feedback from growers like PurNatur. This development marks a significant milestone for NRGene, showcasing its ability to rapidly bring innovative solutions to market and address critical challenges in the agriculture industry.
Product StageCustomersPartners
growth-positive
/CNW/ -- NRGene Green, a global leader in AI-driven genomics for crop improvement, today announced breakthrough field trial results confirming complete...
NRGene Green, a leader in AI-driven genomics for crop improvement, announced a breakthrough in field trials demonstrating complete resistance to clubroot in canola. This innovation, developed in Saskatchewan, marks the first field demonstration of immunity-level resistance to this disease, offering significant value to Canadian agriculture. The trials showed that NRGenes advanced donor lines achieved 0% disease incidence, outperforming existing industry standards. This breakthrough is expected to transform global oilseed production, providing Canadian farmers with robust defense against clubroot. The resistant lines are now available for licensing to commercial breeding programs, opening opportunities for seed companies to secure these traits. NRGene Greens technology combines genomics and AI tools to identify natural resistance genes, supporting rapid regulatory acceptance and global deployment.
Product StagePartners
growth-positive
NRGene Achieves Full Clubroot Resistance in Canola and Moves Toward Commercialization in Canada
NRGene Green, a leader in AI-driven genomics for crop improvement, has announced groundbreaking field trial results demonstrating complete resistance to clubroot in canola. This innovation, developed in Saskatchewan, is a significant advancement for Canadian agriculture, offering robust defense against a disease that threatens global oilseed production. The trials showed that NRGenes advanced donor lines achieved 0% disease incidence, outperforming existing industry standards. This breakthrough is expected to enhance food security and drive sustainable agricultural practices worldwide.
Product Stage
growth-positive
Middle Eastern Market: 3 Penny Stocks With Market Caps Over US$10M To Watch
Apex Investment PSC, a company with a market capitalization of AED13.40 billion, has reported significant earnings growth despite a decline in sales. For Q2 2025, the companys net income increased to AED97.2 million from AED18.74 million the previous year, with a substantial rise in basic earnings per share. Apex Investment PSC operates in the manufacturing, distribution, and sale of clinkers and cement products, primarily deriving revenue from its Catering segment. Despite having no debt and strong short-term asset coverage, the company experienced decreased profit margins due to one-off losses. The board is considered experienced, with an average tenure of 3.3 years.
growth-positive
Middle Eastern Penny Stocks To Watch In June 2025
The article discusses the positive shift in Middle Eastern markets, particularly highlighting smaller or less-established companies with growth potential. National Investor Pr. J.S.C., operating in the UAE, is one such company with a market cap of AED110.22 million. Despite a net loss of AED10.9 million for 2024, the company has improved its financial health by reducing its debt-to-equity ratio and maintaining more cash than total debt. This ensures a stable financial position with a cash runway for over three years. The companys revenue is primarily generated from its Principal Investments segment, amounting to AED26.21 million. The seasoned board with an average tenure of 6.2 years indicates experienced governance amidst ongoing challenges.
growth-negative
Middle Eastern Penny Stocks With Market Caps Under US$200M
HAYAH Insurance Company P.J.S.C., a provider of health and life insurance solutions in the UAE and internationally, has recently reported a net income of AED 0.535 million for Q1 2025, marking its transition to profitability. Despite this, the company faces challenges, including a decline in earnings compared to the previous years first quarter and high volatility in its share price. The company is debt-free and maintains strong liquidity, with short-term assets exceeding liabilities. The management team is experienced, with an average tenure of nearly seven years. However, the low return on equity at 1.7% and declining earnings indicate potential challenges ahead.
growth-positive
Ihlas Gazetecilik Leads Our Trio Of Middle Eastern Penny Stock Picks
Ihlas Gazetecilik A.S., a Turkish publishing company, has shown a significant financial turnaround by transitioning to profitability with a net income of TRY114.35 million for 2024, compared to a loss in the previous year. The company has a market cap of TRY1.09 billion and primarily generates revenue from its newspaper publishing segment. Despite a low return on equity of 3.9%, its price-to-earnings ratio of 9.5x indicates potential undervaluation against the Turkish market average of 18.1x. The companys strong liquidity is evidenced by its short-term assets covering liabilities and cash reserves exceeding total debt. However, investors should be cautious of the high share price volatility and large one-off financial impacts.
growth-positive
March 2025's Middle Eastern Penny Stocks To Watch
The article discusses the potential growth opportunities in Middle Eastern penny stocks, highlighting several companies, including the National Corporation for Tourism and Hotels (NCTH). NCTH, with a market cap of AED 2.09 billion, derives its revenue from catering services, hotels, and retail services. The company reported AED 698.56 million in sales for 2024, with net income rising to AED 74.03 million. Despite past earnings declines, recent profit growth indicates improvement, although the return on equity remains low at 3.2%. The company is financially healthy, with short-term assets exceeding liabilities and debt levels well-covered by cash flow and interest payments. The stock trades at a discount to its estimated fair value, making it attractive to investors seeking undervalued opportunities.
growth-positive
Stronger Canola, Secure Yields: NRGene Canada's Breakthrough in Clubroot Resistance
NRGene Canada has made a significant breakthrough in developing clubroot-resistant traits for canola, a major advancement in the fight against a destructive fungal disease affecting canola crops. This innovation is crucial for the sustainability and yield security of Canadas canola industry, valued at $43.7 billion annually. The company has introduced two new donor lines that demonstrate full resistance to multiple Canadian pathotypes, including the aggressive 5X strain. Utilizing AI-driven genomics and molecular genomics-assisted backcrossing, NRGene has integrated these resistance traits into commercial breeding programs, ensuring long-term protection and adaptability. This development empowers seed companies and farmers with more resilient canola varieties, supporting consistent yields and sustainability.
Product Stage
growth-positive
/PRNewswire/ -- NRGene Canada, a global leader in AI-driven genomics for crop improvement, has achieved a major breakthrough in clubroot-resistant trait for...
NRGene Canada has made a significant breakthrough in developing clubroot-resistant traits for canola, a crucial advancement for the $43.7 billion Canadian canola industry. The company has introduced two new donor lines that provide full resistance to multiple Canadian pathotypes, including the aggressive 5X strain. This innovation, driven by AI and genomics, ensures long-term protection and adaptability in commercial breeding programs. NRGene Green, a sister company, has been established to focus on the commercialization of these resistant traits, partnering with seed companies, growers, and research institutions. The resistant lines and DNA markers are now available for commercial breeding, aiming to support global markets with high-yielding, clubroot-resistant hybrids.
Partners
growth-positive
NRGene Canada and Northern Indigenous Fish Company Partner to Drive Circular Economy with BSF in Saskatchewan
NRGene Canada Inc., an AI-driven genomics company, has partnered with Ile-a-la-Crosse Fish Company Inc. to transform fish waste into sustainable protein and fertilizers using Black Soldier Fly (BSF) technology. This collaboration aims to promote circular economy practices and create economic opportunities in Saskatchewan. The project will optimize BSF larvae to convert fish processing waste into high-quality protein for pet food and aquaculture, as well as nutrient-rich fertilizers. A commercial-scale facility will be established to process large volumes of fish waste, supporting a sustainable and diversified economy. This initiative aligns with Saskatchewans innovation goals, reduces greenhouse gas emissions, and positions the region as a leader in sustainable protein alternatives.
Partners
growth-positive
Bühler and NRGene Canada open North American Insect Center
Swiss technology group Bühler and NRGene Canada, a subsidiary of Israeli genomics company NRGene Technologies, have launched the North American Insect Center (NAIC). The center is designed to optimize the production of insect protein in North America, specifically from Black Soldier Fly (BSF) varieties. The NAIC will also support investors in evaluating the economic viability of larger plants before committing to full-scale investment. The center will offer customer trials, workshops, training sessions, and seminars to disseminate best practices in insect protein production.
PartnersExpand
growth-positive
NRGene Canada and Bühler Launch North American Insect Center for Sustainable Protein Production
NRGene Canada, a subsidiary of NRGene, has announced the opening of the North American Insect Center (NAIC) in collaboration with Swiss technology group Bühler. The center, located in Saskatchewan, will serve as a research and testing facility for customers to evaluate the performance of Black Soldier Fly (BSF) varieties. The NAIC aims to support the growth of the insect protein industry in North America by offering workshops, training sessions, and seminars. NRGenes extensive BSF variety collection, combined with advanced genomics and phenotyping capabilities, enables the development of tailored BSF strains with improved functionalities.
PartnersExpand
growth-positive
NRGene Advances Mas Seeds Maize Seed Breeding with its Comprehensive Genotyping Solutions
NRGene, a genomics AI company, and Mas Seeds, an international seed company, have announced the completion of a milestone in their 4-year collaboration agreement. The partnership aimed to enhance Mas Seeds maize breeding program and reduce genotyping costs using NRGenes genotyping and imputation solution, SNPer™. The collaboration has resulted in a 50% reduction in genotyping costs, improved quality assurance, and better prediction accuracy. The companies are considering expanding this model to other crops and activities.
Partners
growth-positive
NRGene Advances Mas Seeds Maize Seed Breeding with its Comprehensive Genotyping Solutions
NRGene, a genomics AI company, and Mas Seeds, an international seed company, have announced the completion of a milestone in their 4-year collaboration agreement. The partnership aimed to enhance Mas Seeds maize breeding program and reduce genotyping costs using NRGenes genotyping and imputation solution, SNPer™. The collaboration has resulted in a 50% reduction in genotyping costs and improved the quality of Mas Seeds selective breeding program. The companies are considering expanding this model to other crops and activities.
PartnersExpand
growth-positive
NRGene Establishes Supree, a Food-Tech Company developing Self-Drying Fruits and Vegetables
NRGene Technologies Ltd. has launched a FoodTech subsidiary, Supree, which specializes in developing fruit and vegetable varieties that naturally dry on the vine while retaining nutritional value and flavor. Suprees first product line is a unique semi-dried tomato variety. The company is targeting premium B2B markets in Israel, Europe, and the Middle East, including restaurants, hotels, catering companies, and food manufacturers. The potential market size for Suprees tomatoes is estimated to reach USD 1.5 billion by 2030. Supree has also signed a partnership agreement with Tzabar Tech to facilitate the production and processing of the product.
CustomersPartnersExpand
growth-positive
Above Food Corp. to Acquire AI-based Genomic Assets, Intellectual Property and Trait Development Technology Licensing Rights from NRGene
Above Food Corp. has announced an asset-purchase agreement with NRGene Technologies Ltd. to acquire AI-based genomic assets, intellectual property, and trait development technology licensing rights. The transaction is contingent on the closing of Above Foods business combination with BITE Acquisition Corp. and the subsequent listing of the combined companys common shares on the New York Stock Exchange. NRGene will receive a combination of cash and stock-based consideration, as well as royalties from commercialization of specific projects. The acquisition is expected to accelerate the creation of elite varieties with genetic traits valuable to the food industry.
Acquisition
Bühler and NRGene collaborate to increase competitiveness of black soldier fly industry
Canola Clubroot Disease: Winning the Fight Has Never Been Closer!
A High-Resistance ToBRFV Tomato Variety is Within Reach - NRGene and Philoseed Announce Successful Resistance Validation by Customers.
Strategic Collaboration to Address the Global Food Crisis: NRGene and Granot Group Develop Elite Varieties for Vertical Farming
Strategic Collaboration to Address the Global Food Crisis: NRGene and Granot Group Develop Elite Varieties for Vertical Farming
growth-positive
אנרג'ין מדווחת כי הלקוח אשר ביקש לבטל את עסקת מתן הרישיון חזר בו מבקשת הביטול
EnerGene Technologies Ltd., an AI company providing innovative solutions for the development of elite varieties in agricultural crops and animals, reports that a seed company that sought to cancel the license agreement for the cultivation and trade of tomato varieties resistant to the ToBRFV virus last month, has reached understandings with EnerGene. Therefore, the agreement between the parties remains in effect and the seed company withdraws its cancellation request. EnerGene will provide the tomato seeds containing the resistance trait to the customer. EnerGene expects to sign additional license agreements for the cultivation and trade of tomato seeds resistant to the ToBRFV virus, after its distribution expanded significantly during 2021.
CustomersPartners
NRGene Accelerates Growth with a New Office and Genotyping Lab in Canada
growth-positive
אנרג'ין מקימה מעבדה גנטית בקנדה
The Israeli company Energin, which operates in the seed enhancement industry using artificial intelligence, announced today the expansion of its operations abroad. The company is setting up a dedicated laboratory in Canada to perform genetic tests for its customers. The company expects the new laboratory to start operating in 2021 and to generate revenues of about $20 million for the company during 2021-2025. The laboratory will be set up by the company in Canada during 2021 and will provide genetic testing and interpretation services for various crops.
ExpandInvestment
growth-positive
Canola/Rapeseed Pan-Genome Consortium Results Reveal Broad Genetic Diversity of the Crop
A consortium of academic and commercial companies, including NRGene, has successfully completed the canola/rapeseed pan-genome. The consortium was led by Dr. Isobel Parkin from Agriculture & Agri-food Canada, Dr. Andrew Sharpe from the Global Institute for Food Security at the University of Saskatchewan, and NRGene. The consortium included key players in the canola industry, such as Bayer, Corteva Agriscience, Nutrien Ag Solutions, and Nuseed. The pan-genome will be used by the consortium members and will be available to the entire canola breeding and research community after scientific publication.
PartnersCustomers
growth-positive
AI genomics co NRGene raises NIS 100m in TASE IPO
Israeli AI-based genomic company NRGene has completed its IPO on the Tel Aviv Stock Exchange, raising NIS 100 million at a company valuation of NIS 370 million. The funds will be used to accelerate growth, expand market share, and create long-term collaborations. NRGene develops AI software solutions for analyzing genomics big data to enhance breeding processes in plants and animals. The company already partners with leading agricultural companies such as Bayer and Syngenta and plans to expand its global activities in the agriculture and food industry. NRGene has adopted a new business model of joint IP development with customers, and has signed royalties-based agreements for the development and sale of seeds. The IPO was led by IBI and Epsilon underwriters.
Public TradingInvestment
growth-positive
AI genomics co NRGene files for $40m TASE IPO
Israeli AI genomics company NRGene has filed for an IPO on the Tel Aviv Stock Exchange. The company aims to raise $40 million at a valuation between $150 and $200 million. NRGene uses AI and big data to analyze genetic information and enhance plant and livestock genes. The companys technology allows customers to develop resilient plants and has attracted large companies like Bridgestone, Syngenta, Bayer, and Mondelez as customers. NRGenes financial statement has a going concern qualification due to insufficient revenue, but the company reduced expenses and losses. The IPO will be led by IBI and Epsilon underwriters. The Covid-19 crisis caused a delay in NRGenes analyses and a 26% revenue decline in the first half of 2020.
Public TradingInvestment
אנרג'ין בדרך להנפקה לפי שווי של 200 מיליון דולר
NRGene Introduces New Product to Allow Crop Genotyping Optimization at Lower Costs
growth-positive
Why Gil Ronen Picked Canada as a Place to Innovate - Germination
NRGene, a genomics AI company, has chosen Saskatchewan for its Canadian head office. The CEO and co-founder, Dr. Gil Ronen, discusses the reasons behind this decision.
Partners
growth-positive
Saskatchewan Welcomes NRGene to Province - NRGene - the leading genomic big data company
NRGene, a genomics company headquartered in Israel, is expanding its operations to Canada and opening an office in Saskatoon, Saskatchewan. The investment from NRGene follows a successful trade mission to Israel in 2018, where the Government of Saskatchewan highlighted opportunities in the province. NRGene provides turn-key solutions for agricultural research and breeding using genomic databases and AI-based technologies. The company has collaborated with various organizations in Saskatchewan on genomics projects for crops like wheat and canola. With this expansion, NRGene plans to recruit skilled geneticists and data scientists to their new office in Saskatoon. The announcement is seen as a positive sign for Saskatchewans investment climate and will enhance the provinces AgTech sector and agri-food productivity.
InvestmentExpand
growth-positive
BASF and NRGene Collaborate to Accelerate Crop Breeding - Seed World
BASF and NRGene have announced a research collaboration to adopt NRGenes AI technology into BASF soybean research projects. The collaboration aims to improve and accelerate agricultural research, aligning with BASFs soybean crop system strategy. NRGenes GenoMAGIC technology will enable more comprehensive evaluations to accelerate trait discovery and breeding across diverse crops. BASFs focus on data and digitalization will allow for better breeding decisions. The collaboration is expected to make breeding more productive and efficient for BASF.
Partners
NRGene Achieves Advanced Technology Partner Status in the Amazon Web Services Partner Network
Introducing the First Fully-Phased Cannabis Genome: NRGene and Kayagene Breakthrough Enables Growers to Fast-Track Breeding and Strain Development
growth-positive
NRGene and Macrogen Launch Unltra-High-Density SNP Genotyping Service
NRGene and Macrogen Corp have launched a joint sequencing-based genotyping service called ArrayMAGIC. The service provides affordable ultra-high-density single nucleotide polymorphism (SNP) genotyping for agricultural applications. The collaboration aims to make high-quality SNP genotyping more accessible and affordable for a wide range of customers. The service will initially be available for soy and maize, with plans to expand to more organisms later this year. The partnership combines the technology and capabilities of NRGene, Macrogen, and iGenomX, providing a superior genotyping service at a low cost. The collaboration is expected to optimize sequencing-based genotyping tools for researchers.
PartnersCustomers
growth-positive
Japan: NRGene and Toyota to develop strawberry varieties for local production
NRGene and Toyota have successfully decoded the genome of a commercial strawberry, which will aid in the development of high-quality strawberries for the Japanese market. NRGenes genomic big-data AI tool, combined with Toyotas DNA analysis technology, will enhance the breeding efficiency and development of natural strawberry varieties. This project aligns with Toyotas efforts to support the agricultural industry and improve food security. NRGenes genome assembly has been praised for its ability to support genomics-based breeding. The collaboration between NRGene and Toyota is expected to continue to meet plant breeding goals.
Partners
NRGene and Syngenta Expand Genomics Collaboration in Key Crops
growth-positive
NRGene Announces Expanded Licensing Agreement with Bayer for the GenoMAGIC™ Platform
NRGene, a global leader in genomic analysis, has announced a significant milestone in its multi-year licensing agreement with Bayer. The agreement allows Bayer to use GenoMAGIC, a cloud-based big data analytics platform, to support its molecular breeding program within its Crop Science Division. Bayer has completed a one-year evaluation of GenoMAGIC and has tested its usability to compare genetic makeup and select the best candidates for molecular breeding. The licensing agreement was originally signed by Monsanto Company prior to its acquisition by Bayer.
Partners
growth-positive
NRGene and Kayagene, LLC. Collaborate to Improve Cannabis Breeding and Seed Production
Kayagene, a cannabis breeding company, is collaborating with NRGene, an agricultural genomics company, to enhance breeding capabilities and develop improved cannabis varieties. The partnership aims to sequence and assemble multiple genomes of diverse cannabis lines to enhance valuable traits. NRGenes DeNovoMAGIC[TM] 3.0 will be used for genome assemblies, increasing genetic gain and reducing breeding program cycles. The collaboration will result in tailored cannabis varieties for customers needs, including healthier plants and custom cannabinoid profiles. The partnership is expected to benefit both companies and the cannabis industry as a whole.
Partners
growth-positive
NRGene and RCK to Develop DNA Tests for Medical Cannabis
RCK, a licensed cannabis cultivation company in Israel, has partnered with NRGene, a genome analysis company, to develop DNA markers for strain identification of cannabis plants grown for medical use. The partnership aims to ensure top quality control of plant material production for medical treatment. The DNA markers will be used for strain authentication and to discover key traits in cannabis for more efficient breeding. The global use of medical cannabis is expanding rapidly, and the accuracy achieved by the DNA marker analysis is crucial for the effectiveness of therapy. The partnership addresses the need for reliable methods to distinguish among cannabis strains.
Partners
growth-positive
NRGene partners with Pure Cannabis Research AG to develop novel cannabis varieties
NRGene has partnered with Pure Cannabis Research AG to enhance R&D for new and improved cannabis varieties. The partnership will facilitate the rapid development of tailored cannabis varieties for customers needs, including healthier plants and custom cannabinoid profiles. NRGene will use its DeNovoMAGIC™ and PanMAGIC™ technologies to assemble multiple cannabis genomes and create the worlds first cannabis pangenome. The pangenome project will provide insights into the natural genetic diversity of cannabis. NRGenes GenoMAGIC™ platform will be used to identify markers for key traits. The partnership is expected to contribute to the growth of NRGene in the genomics industry.
Partners
growth-positive
Major Step Forward in Chickpea and Pigeonpea Research - Reference Genome Data Assembled by NRGene & the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT)
Scientists from ICRISAT and NRGene have collaborated to create multiple assembly lines of pigeonpea and chickpea genomes, allowing for better understanding of crop traits and faster work on improved varieties. The technology from NRGene has provided reference genomes of chickpea and pigeonpea to a high quality, maximizing their nutritional properties. This is particularly important for addressing food security in the developing world with limited farmland. Traditional methods would have taken years to complete each assembly, but NRGenes technology has delivered multiple assemblies in a matter of months. Chickpea and pigeonpea are critical food sources in India, Africa, and the Caribbean, and addressing protein hunger is a major concern in Asia. The collaboration between ICRISAT and NRGene aims to improve the nutrition status of the world.
Partners
growth-positive
Israel's NRGene helps unveil genetic makeup of soybeans
Israeli startup NRGene has helped assemble two genomes of the soybean, which will help farmers improve the quality of their crops. The gene assembly software provided by NRGene was used by researchers to map the genomic makeup of two soybean varieties. This will enable scientists to increase the oil and protein content of soybeans through traditional breeding methods. The project was funded by the United Soybean Board and three private companies. NRGenes software is widely used by seed companies and academic researchers globally.
PartnersInvestment
growth-positive
NRGene teams with Bridgestone to develop resilient rubber-producing plants
NRGene, an Israeli gene mapping startup, has partnered with Bridgestone Americas Inc. to develop a more resilient rubber-producing plant. The collaboration aims to sequence and assemble genomes of guayule, an undomesticated American shrub, in order to breed better and stronger varieties of the plant for rubber production. NRGene has already sequenced and assembled two guayule genomes and is developing a physical and genetic map for breeding improvement. The partnership will help Bridgestone increase its rubber yield and develop a sustainable guayule natural rubber industry in North America. NRGenes software is used by leading seed companies and academic researchers worldwide.
Partners
growth-positive
NRGene Delivers First-ever Food Potato Genomes
NRGene is working with researchers from Wageningen University & Research and commercial partners to create multi-genome mapping of commercial food potatoes. NRGene has completed the phased assembly of three commercial potato varieties, providing a solution for the potato breeding and research community. The potato pangenome will contribute to a comprehensive genomics view of the potato genome. NRGene has achieved a prominent position in world agriculture, delivering over 300 crop genomes in the past two years. The companys tools have been employed by leading seed companies and research teams. The potato genome research will be presented at the PAG XXVI conference in January 2018.
Partners
growth-positive
NRGene & Tel Aviv Medical Center Collaborate on Parkinson's
NRGene has partnered with the Genetic Institute of Tel Aviv Sourasky Medical Center (TASMC) to perform genomic analysis of Parkinson’s disease (PD). NRGenes GenoMAGIC system will efficiently analyze the genomic data of a Parkinson’s patients cohort and identify individuals’ unique genomic makeup. The collaboration aims to improve understanding, treatment, and prevention of Parkinson’s disease.
Partners
growth-positive
Israel's NRGene identifies mutation that causes colon cancer
NRGene, an Israeli company known for mapping the genome of various crops, has successfully identified a mutation that causes colon cancer through genomic analysis. The companys software can accurately and quickly detect genetic abnormalities and mutations in humans, potentially leading to early detection and prevention of diseases. NRGene is now focusing on the human genome and healthcare market, which is larger than the agricultural market it previously served. The study, conducted in collaboration with Stanford University, analyzed the genetic composition of a family with inherited colon cancer and successfully identified the mutation causing the disease. NRGenes software was faster and more accurate compared to existing systems. The companys software can also be used by researchers, medical professionals, and pharmaceutical companies for personalized medicine development.
Customers
growth-positive
NRGene Delivers Major Breakthrough in Sunflower Genome
NRGene has created a comprehensive version of the sunflower genome for a cooperative of scientists. The genome analysis significantly accelerates research and enables the identification of genetic changes responsible for the origin of species. The data will be used to enhance the ability to breed hardier sunflower varieties. NRGenes DeNovoMAGIC reduced the sunflower assembly process to less than a month, allowing researchers to shift their focus to genome analysis. NRGene will continue collaborating with scientists as part of the sunflower pangenome project to compare multiple varieties and breed more efficient plants. NRGene is a genomic big data company developing software and algorithms for advanced breeding programs.
Partners
growth-positive
NRGene's Genomic Analysis Project With Monsanto Advances
NRGene has progressed in its multi-year agreement with Monsanto, integrating part of Monsantos genomic data into GenoMAGICTM, a cloud-based big data analytics platform. This integration allows Monsanto to evaluate the platforms ability to predict, compare, and select the best genetic makeup for molecular breeding. If successful, the GenoMAGICTM platform will improve Monsantos genomics and trait data evaluation, enabling more efficient development of new crop varieties. NRGene is a genomic big data company that develops software and algorithms for advanced breeding programs.
Partners
growth-positive
NRGene Delivers an Improved Sweet Potato Genome
NRGene has delivered an improved assembly of the sweet potato genome to a group of scientists from Japan, China, and Korea. The genome sequencing was performed as part of a project sponsored by the Trilateral Research Association of Sweet Potato. NRGenes technology allowed for the quick and efficient analysis of the sweet potato genome, providing essential data on critical crops in a matter of weeks. The next step in the research is creating a sweet potato pan-genome, which will allow researchers to breed sweet potatoes with higher nutritional values and productivity. NRGene is a genomic Big Data company developing software and algorithms for advanced breeding programs.
Partners
growth-positive
NRGene Assembles its 300th Crop Genome
NRGene, a genomic mapping company, has assembled 300 genomes of major crop plants in less than two years, allowing for highly accurate genome comparisons for breeding better seeds. NRGenes technology has significantly reduced the time and improved the accuracy of genome production. The company has collaborated with leading universities, research institutes, non-profit organizations, and global companies like Syngenta and Monsanto. NRGenes DeNovoMAGIC 3.0 delivers reference genomes quickly and cost-effectively, without requiring external data. The companys PanMAGIC combines initial assemblies into an accurate genome-to-genome mapping to capture the full diversity of crop varieties. NRGenes tools have been used by seed companies and research teams worldwide.
Partners
growth-negative
Some see Monsanto acquisition as an opportunity
Creve Coeur-based Monsanto is likely to be acquired by Bayer, which is viewed as a positive by the startup community. The acquisition will bring new money and ideas flowing into startups, as well as massive amounts of agricultural expertise. The North American headquarters of the combined company will be located in St. Louis, ensuring that most research jobs will be safe. However, layoffs are expected in Monsantos corporate offices. Startups already dealing with Monsanto or hoping to do so see the acquisition as a positive, as it means their customers are getting bigger and their technology is more relevant. While the loss of a corporate headquarters is generally seen as negative, there are opportunities for young companies to grow.
AcquisitionLayoffs
Israeli tech company NRGene to open St. Louis office
growth-positive
Israeli NRGene and International Researchers Team to Map Key Wheat Genome
NRGene, a genomics AI company, has partnered with global researchers to decode the genome of wild emmer wheat, a variety important for crop improvement. The genome assembly will be performed by NRGene using its DeNovoMAGICTM assembler. The project, which is expected to be completed in six months, will facilitate the genetic identification necessary for continuing wheat improvement. The research partners include Tel Aviv University, Hebrew University, Weizmann Institute of Science, University of Haifa, Ben Gurion University, and the Volcani Institute for Agricultural Research in Israel; Sabanci University in Turkey; and Leibniz Institute of Plant Genetics and Crop Plant Research in Germany.
Partners
NRGene Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 31 |
| Team members | 6 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 12 classification IDs that could be used for matching.
NRGene Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514240779 |
| Crunchbase | nrgene |
| Phone | +972722203750 |
| Creator | Yamila Silbert |
| Creator email | yamila.urwicz@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wain@gmail.com |
| Last update | 2021-03-31T00:00:00.000Z |
| Created | 2015-01-25T00:00:00.000Z |
| Claimed | Yes |
| Status detail | Public on TASE on Jan, 2021<br> |